Summary
O 6-Methylguanine is a substrate of the DNA repair enzymeO 6-methylguanine-DNA methyltransferase, which is involved in the repair mechanism of DNA damage induced by chloroethylnitrosoureas such as 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU). We tested the enhancement effect ofO 6-methylguanine pretreatment on ACNU cytotoxicity in ACNU-resistant brain tumors. Exposure toO 6-methylguanine at various times ranging from 2 to 48 hours increased the cytotoxic effects of ACNU on C6-1 cells, and this effect was highest at higher concentrations 500 and 1,000 μM. Colorimetric cytotoxicity assay revealed at least a two-fold increase in ACNU cytotoxicity relative to controls withoutO 6-methylguanine. Intraarterial ACNU after treatment withO 6-methylguanine (two intravenous bolus injections of 80 and 40 mg/kg) significantly (P < 0.05 or P < 0.01) reduced the proliferation activity of transplanted C6-1 tumors for 96 hours after injection, whereas intravenous ACNU together withO 6-methylguanine significantly (P < 0.05) reduced C6-1 activity for only 48 hours. Thus, pretreatment withO 6-methylguanine prolonged the suppression effect of ACNU. The C6-1 tumors treated only with intravenous or intraarterial ACNU showed transient inhibition and rapid regrowth for 24 hours after treatment. These results indicate thatO 6-methylguanine increases ACNU cytotoxicity in anin vitro andin vivo brain tumor model.
Similar content being viewed by others
References
Walker MD, Green SO, Bvar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N Engl J Med 303: 1323–1329, 1980
Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M, Nomura K: Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53–57, 1986
Shapiro WR, Green SB, Burger PC, Mahaley MS, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J, Strike TA, Pistenmaa DA: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71: 1–9, 1989
Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, Shapiro WR, Mealey J, Ransohoff J, Paoletti P, Smith KR, Odom GL, Hunt WE, Young B, Alexander E, Walker MD, Pistenmaa DA: Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractioned radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 16: 1389–1396, 1989
Mahaley MS: Neuro-oncology index and review (adult primary brain tumors). J Neurooncol 11: 85–147, 1991
Hochberg FH, Pruitt AA, Beck DO, DeBrun G, Davis K: The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma. J Neurosurg 63: 876–880, 1985
Bashir R, Hochberg FH, Linggood RM, Hotteleman K: Preirradiation internal carotid artery BCNU in treatment of glioblastoma multiforme. J Neurosurg 68: 917–919, 1988
Roosen N, Kiwit JC, Lins E, Schirmer M, Bock WJ: Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain. Experience at the Department of Neurosurgery of Dusseldorf University. Cancer 64: 1984–1994, 1989
Hori T, Muraoka K, Saito Y, Sasahara K, Inagaki H, Inoue Y, Adachi S, Anno Y: Influence of models of ACNU administration on tissue and blood concentration in malignant brain tumors. J Neurosurg 66: 372–378, 1987
Mineura K, Watanabe K, Izumi I, Kowada M: Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration. J Neurooncol 14: 201–205, 1992
Rosenblum ML, Gerosa MA, Bodell WJ, Talcott RL: Tumor cell resistance. Prog Exp Tumor Res 27: 191–214, 1984
Mineura K, Fushimi S, Itoh Y, Kowada M: DNA lability induced by nimustine (ACNU) and ramustine (MCNU) in rat glioma cells. J Neurol Neurosurg Psychiatry 51: 1391–1394, 1988
Dolan ME: Reduction ofO 6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated withO 6-alkylguanine. Cancer Res 45: 6413–6417, 1985
Dolan ME, Young GS, Pegg AE: Effects ofO 6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents. Cancer Res 46: 4500–4504, 1986
Dolan ME, Pegg AE, Hora NK, Erickson LC: Effect ofO 6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosourea and 2-chloroethyl(methylsulfonyl) methanesulfonate. Cancer Res 48: 3603–3606, 1988
Gerson SL, Trey JE, Miller K: Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivationO 6-alkylguanine-DNA-alkyltransferase. Cancer Res 48: 1521–1527, 1988
Dexter EU, Yamashita TS, Donovan C, Gerson SL: Modulation ofO 6-alkylguanine-DNA alkyltransferase in rats following intravenous administration ofO 6-methylguanine. Cancer Res 49: 3520–3524, 1989
Balsiger RW, Montgomery JA: Synthesis of potential anticancer agents. XXV. Preparation of 6-alkoxy-2-aminopurines. J Org Chem 25: 1573–1575, 1960
Benda P, Lightbody J, Sato G, Levine L, Sweet W: Differentiated rat glial cell strain in tissue culture. Science 161: 370–371, 1968
Mosmann T: Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63, 1983
Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203–210, 1989
Zar JH: Biostatistical Analysis. Prentice-Hall Inc, Englewood Cliffs, New Jersey, USA, 1984, pp 138–145
Nikkhah G, Tonn JC, Hoffmann O, Kraemer HP, Darling JL, Schonmayr R, Schachenmayr W: The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables. J Neurooncol 13: 1–11, 1992
Nikkhah G, Tonn JC, Hoffmann O, Kraemer HP, Darling JL, Schachenmayr W, Schonmayr R: The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient-and drugspecific variables. J Neurooncol 13: 13–24, 1992
Mineura K, Fushimi S, Sasaki J, Sasajima H, Ishino Y, Kowada M: Circumvention of ACNU-resistance in rat glioma cells by pretreatment withO 6-methylguanine. Jpn J Cancer Chemother 16: 259–262, 1989 (Japanese)
Wiestler O, Kleihues P, Pegg AE:O 6-Alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis 5: 121–124, 1984
Frosina G, Rossi O, Arena G, Gentile SL, Bruzzone E, Abbondandolo A:O 6-Alkylguanine-DNA alkyltransferase activity in human brain tumors. Cancer Lett 55: 153–158, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mineura, K., Izumi, I., Watanabe, K. et al. Enhancement of ACNU cytotoxicity by pretreatment withO 6-methylguanine in ACNU-resistant brain tumors. J Neuro-Oncol 19, 51–59 (1994). https://doi.org/10.1007/BF01051048
Issue Date:
DOI: https://doi.org/10.1007/BF01051048